Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
Top Cited Papers
- 8 December 2004
- journal article
- review article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 27 (6) , 503-514
- https://doi.org/10.1111/j.1365-2885.2004.00603.x
Abstract
The rise in incidence of antimicrobial resistance, consumer demands and improved understanding of antimicrobial action has encouraged international agencies to review the use of antimicrobial drugs. More detailed understanding of relationships between the pharmacokinetics (PK) of antimicrobial drugs in target animal species and their action on target pathogens [pharmacodynamics (PD)] has led to greater sophistication in design of dosage schedules which improve the activity and reduce the selection pressure for resistance in antimicrobial therapy. This, in turn, may be informative in the pharmaceutical development of antimicrobial drugs and in their selection and clinical utility. PK/PD relationships between area under the concentration time curve from zero to 24 h (AUC0‐‐24) and minimum inhibitory concentration (MIC), maximum plasma concentration (Cmax) andMICand time during which plasma concentrations exceed theMIChave been particularly useful in optimizing efficacy and minimizing resistance. Antimicrobial drugs have been classified as concentration‐dependent where increasing concentrations at the locus of infection improve bacterial kill, or time‐dependent where exceeding theMICfor a prolonged percentage of the inter‐dosing interval correlates with improved efficacy. For the latter group increasing the absolute concentration obtained above a threshold does not improve efficacy. The PK/PD relationship for each group of antimicrobial drugs is ‘bug and drug’ specific, although ratios of 125 forAUC0‐‐24:MICand 10 forCmax:MIChave been recommended to achieve high efficacy for concentration‐dependent antimicrobial drugs, and exceedingMICby 1–5 multiples for between 40 and 100% of the inter‐dosing interval is appropriate for most time‐dependent agents. Fluoroquinolones, aminoglycosides and metronidazole are concentration‐dependent and beta‐lactams, macrolides, lincosamides and glycopeptides are time‐dependent. For drugs of other classes there is limited and conflicting information on their classification. Resistance selection may be reduced for concentration‐dependent antimicrobials by achieving anAUC0‐‐24:MICratio of greater than 100 or aCmax:MICratio of greater than 8. The relationships between time greater thanMICand resistance selection for time‐dependent antimicrobials have not been well characterized.Keywords
This publication has 78 references indexed in Scilit:
- Pharmacokinetic–pharmacodynamic integration of danofloxacin in the calfResearch in Veterinary Science, 2003
- The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibioticsResearch in Veterinary Science, 2002
- Quinolone-ResistantCampylobacter jejuniInfections in Minnesota, 1992–1998New England Journal of Medicine, 1999
- Role of Population Pharmacokinetics in Drug DevelopmentClinical Pharmacokinetics, 1997
- Efficacy of beta-lactam antibiotics: Integration of pharmacokinetics and pharmacodynamicsDiagnostic Microbiology and Infectious Disease, 1997
- Aminoglycoside Administration as a Single Daily DoseDrugs, 1996
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- Measuring the comparative efficacy of antibacterial agents for acute otitis media: The “Pollyanna phenomenon”The Journal of Pediatrics, 1992
- Clinical Significance of Antibiotic Tissue PenetrationClinical Pharmacokinetics, 1989